Vimentin 3, the New Hope, Differentiating RCC versus Oncocytoma

Vimentin 3, the New Hope, Differentiating RCC versus Oncocytoma

Vimentin is currently used to differentiate between malignant renal carcinomas and benign oncocytomas. Recent reports showing Vimentin positive oncocytomas seriously question the validity of this present diagnostic approach. Vimentin 3 is a spliced variant and ends with a unique C-terminal ending af...

Full description

Bibliographic Details
Main Authors: Melanie von Brandenstein, Katharina Puetz, Monika Schlosser, Heike Löser, Joachim P. Kallinowski, Daniel Gödde, Reinhard Buettner, Stefan Störkel, Jochen W. U. Fries
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2015/368534

Internet

http://dx.doi.org/10.1155/2015/368534

Similar Items